tiprankstipranks
Telix Pharmaceuticals Ltd. (AU:TLX)
ASX:TLX
Australian Market

Telix Pharmaceuticals Ltd. (TLX) Income Statement

Compare
251 Followers

Telix Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2024), Telix Pharmaceuticals Ltd.'s total revenue was AU$188.96M, an increase of 685.81% from the same quarter last year. In Q2, Telix Pharmaceuticals Ltd.'s net income was AU$11.68M. See Telix Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
AU$ 496.66MAU$ 160.10MAU$ 7.60MAU$ 5.21MAU$ 3.48M
Gross Profit
AU$ 308.50MAU$ 29.34MAU$ -29.77MAU$ -16.88MAU$ -11.88M
Operating Expenses
AU$ 311.54MAU$ 102.52MAU$ 51.48MAU$ 32.38MAU$ 28.38M
Depreciation and Amortization
AU$ 6.74MAU$ 5.38MAU$ 5.17MAU$ 4.88MAU$ 4.24M
EBITDA
AU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -44.94MAU$ -36.17M
Operating Income
AU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25MAU$ -40.26M
Other Income/Expenses
AU$ -48.80MAU$ -24.52MAU$ -17.79MAU$ -11.00MAU$ 9.13M
Pretax Income
AU$ 3.09MAU$ -98.62MAU$ -99.04MAU$ -60.25MAU$ -42.81M
Net Income
AU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89MAU$ -27.87M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ 0.02AU$ -0.34AU$ -0.29AU$ -0.17AU$ -0.12
Diluted EPS
AU$ 0.02AU$ -0.34AU$ -0.29AU$ -0.17AU$ -0.12
Weighted Average Shares Outstanding
319.18M 310.64M 282.21M 257.27M 233.44M
Weighted Average Shares Outstanding (Diluted)
323.71M 310.64M 282.21M 257.27M 233.44M
Currency in AUD

Telix Pharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis